Insider trades

Rachlin Evan Lockwood

Rachlin Evan Lockwood made 1 buy and 0 sales on the open market in the last 12 months at Iambic Therapeutics, Inc. Each trade with the role, price and filing.

Insider trades

Where they report

CompanyRoleHolding afterLatest trade
Iambic Therapeutics, Inc.
NASDAQ:IAM
Director57,754Oct 16, 2026

Open-market trades, newest first

CompanyDateTradeSharesPriceValueHolding afterFiled
Iambic Therapeutics, Inc.
NASDAQ:IAM
Oct 16, 2026Buy718,750US$16.00US$11.5M2.59MOct 19, 2026